Evidence map›Paper›PMID 37824651›Full record

ArticleScience (New York, N.Y.)2023

Exploiting the Marcus inverted region for first-row transition metal-based photoredox catalysis.

Amy Y Chan, Atanu Ghosh, Jonathan T Yarranton, Jack Twilton, Jian Jin, Daniela M Arias-Rotondo, Holt A Sakai, James K McCusker, David W C MacMillan

Abstract read
In one paragraph

Article in Science (New York, N.Y.), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Synthetic Mechanism of a Fe(II)Inorganic chemistry · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amy Y Chan *Merck Center for Catalysis at Princeton University, Princeton, NJ 08544, USA.ORCID 0009-0002-6492-5873
Atanu Ghosh *Department of Chemistry, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0003-2621-2215
Jonathan T YarrantonDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0003-3134-962X
Jack TwiltonMerck Center for Catalysis at Princeton University, Princeton, NJ 08544, USA.ORCID 0000-0003-3500-4901
Jian JinMerck Center for Catalysis at Princeton University, Princeton, NJ 08544, USA.ORCID 0000-0001-9685-3355
Daniela M Arias-RotondoMerck Center for Catalysis at Princeton University, Princeton, NJ 08544, USA.ORCID 0000-0002-6427-898X
Holt A SakaiMerck Center for Catalysis at Princeton University, Princeton, NJ 08544, USA.ORCID 0000-0002-9338-1484
James K McCuskerDepartment of Chemistry, Michigan State University, East Lansing, MI 48824, USA.ORCID 0000-0002-5684-3117
David W C MacMillanMerck Center for Catalysis at Princeton University, Princeton, NJ 08544, USA.ORCID 0000-0001-6447-0587

Funding

Photoredox Catalysis Applications in Organometallics and Chemical BiologyR35GM134897 · NIGMS · PRINCETON UNIVERSITY · PI David W MacMillan · 2020 to 2026
$6.3M
NIGMS NIH HHS R35 GM134897
6 · The paper itself

Abstract

Second- and third-row transition metal complexes are widely employed in photocatalysis, whereas earth-abundant first-row transition metals have found only limited use because of the prohibitively fast decay of their excited states. We report an unforeseen reactivity mode for productive photocatalysis that uses cobalt polypyridyl complexes as photocatalysts by exploiting Marcus inverted region behavior that couples increases in excited-state energies with increased excited-state lifetimes. These cobalt (III) complexes can engage in bimolecular reactivity by virtue of their strong redox potentials and sufficiently long excited-state lifetimes, catalyzing oxidative C(sp

Identifiers

PMID37824651
PMCPMC10690870

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.